24 hours Zacks Research Weighs in on Jazz Pharmaceuticals plc’s Q2 2025 Earnings (NASDAQ:JAZZ)MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Equities researchers at Zacks Research lifted their Q2 2025 earnings estimates for Jazz Pharmaceuticals in a note issued to investors on Monday, October 14th. Zacks Research analyst S. Ganoria n…
Earnings · Nasdaq 100 · Pharmaceuticals · Science
X